Howe & Rusling’s Sabra Healthcare REIT SBRA Stock Holding History

Howe & Rusling’s Portfolio SBRA Stock Details SBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-50	Closed	-$1K	–	883
2017 Q3	$1K	Buy	+50	New	+$1.13K	﹤0.01%	843
2015 Q1	–	Sell	-40	Closed	-$1K	–	976
2014 Q4	$1K	Buy	+40	New	+$1.1K	﹤0.01%	862

Other funds holding SBRA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

AAMU

APG Asset Management US New York $13B AUM 5.3% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Howe & Rusling's SBRA Position: Q4 2017 in Review

Howe & Rusling sold out of Sabra Healthcare REIT (SBRA) in Q4 2017, closing a stake of 50 shares — an estimated $1K sold.

Howe & Rusling first reported a position in SBRA in Q4 2014 and held it in 2 quarters. The position peaked at $1K in Q3 2017. 332 funds tracked by Wall St. Rank hold SBRA as of Q4 2017.

Howe & Rusling reported no remaining Sabra Healthcare REIT position as of Q4 2017 after selling out during the quarter.
Howe & Rusling sold 50 Sabra Healthcare REIT shares in Q4 2017, an estimated $1K.
Howe & Rusling first reported a position in Sabra Healthcare REIT in Q4 2014 and held it in 2 quarters.
Howe & Rusling's Sabra Healthcare REIT position peaked at $1K in Q3 2017.
332 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q4 2017.

Based on Howe & Rusling's 13F filing for Q4 2017, filed 24 Jan 2018.